Tofane Global Acquires DIMOCO Messaging to Boost iBASIS Mobile Services
Tofane Global (TOFANE), the leading international communications solutions group, announces today the acquisition of DIMOCO Messaging, a leading global SMS aggregator based in Liechtenstein and Austria that delivers around two billion messages per year.
Business messaging or application-to-person (A2P) has grown into a global market worth an estimated 26.5 billion USD in 2022 and is predicted to reach 38 billion USD in 2025. With only 5% of companies using SMS A2P, business adoption of messaging is still in its infancy but is starting to surge as organizations come to realize that business SMS can become a key revenue generator for mobile operators.**
With this acquisition, TOFANE’s subsidiary iBASIS significantly accelerates its growth, doubling mobile services revenues to reach 20% of the company’s total revenues.
The addition of DIMOCO Messaging enhances iBASIS’s carrier-grade network infrastructure by adding more than 100 direct connections to mobile operators worldwide, ensuring the highest standards of speed and reliability for message termination.
iBASIS geographically expands its global commercial presence with DIMOCO Messaging’s offices located in Liechtenstein, Austria, Germany, and Serbia.
The acquisition also gives direct access to the enterprise market segment where DIMOCO Messaging has an established sales force to serve large financial institutions, leveraging new SMS Application Program Interfaces for system integration, APIs for rapid onboarding, and SMS campaign deployment.
Alexandre Pébereau, CEO, iBASIS, and Founder, CEO, TOFANE:
“TOFANE established itself as the first independent leader through acquisitions in international voice. Today, we are replicating our model in the similar but high-growth Business Messaging sector to build our second pillar. By adding DIMOCO Messaging and its senior team, we are boosting our growth path to become the preferred Tier One partner for our customers in mobile services.”
Cameron Calof, Managing Director, DIMOCO Messaging:
“We are very excited to join iBASIS. The company has built a Tier One reputation as preferred partner for global voice and mobile services. We share the same entrepreneurial spirit, business ethics, and customer-centric approach, and are committed to delivering a high level of quality and reliability for messaging worldwide. We are thrilled for our employees and customers as this acquisition opens a new era of possibilities and growth. iBASIS’ expertise and capabilities are undisputed, and we look forward to continuing to respond to the industry’s fast-growing market requirements together.”
Jeantet acted as exclusive legal adviser, Mazars as finance and tax adviser, Wagram Corporate Finance as financial adviser, and Global Telco Consult – GTC as technical adviser on this acquisition.
* DACH: Deutschland (D), Austria (A), and Switzerland (CH)
** Mobilesquared, Business Messaging Overview at MEF Business Messaging, June 2022
About Tofane Global
Tofane Global (TOFANE) is the leading communications solutions group enabling operators and digital players worldwide with their core strategies, performance, and transformation. Tofane Global acquired and successfully integrated seven companies in the global communications market, becoming the first independent player and innovation enabler across international Voice, Mobile Data and SMS messaging, Internet-of-Things, and 5G. As the result of the acquisitions of Altice Europe N.V., iBASIS, SFR, MEO (former Portugal Telecom), NOS, and Simfony, Tofane Global serves 1,000+ customers worldwide across its presence in 26 countries.
About DIMOCO Messaging
Before its acquisition by Tofane Global, DIMOCO Messaging was owned by BaseTech Ventures, an investment venture that invests in early-stage FinTech, internet, and technology start-ups. DIMOCO Messaging provides high quality, reliable A2P messaging products enabling our enterprise clients to communicate to their customers on a truly global scale. We leverage our relationships with Mobile Network Operators, CPaaS and in-country partners to offer clients direct connectivity, allowing them to optimize communication with their customers and employees seamlessly. DIMOCO Messaging, with offices in Liechtenstein, Austria, Germany, and Serbia, holds an MVNO license and operates a carrier-grade messaging platform with highest quality industry standards.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005012/en/
Contact information
Tofane Global
Céline Gregoire
EVP, Marketing
+1 617.501.2788
cgregoire@iBASIS.net
DIMOCO Messaging
Cameron Calof
Managing Director
+43 664 9699 020
cameron.calof@dimoco.eu
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin